

infertility & reproductive technologies | Research | Treatment | 10 pages | source: Scientific reports | Added May 17, 2023
Evaluating the effectiveness of injections of autologous endometrial cells and platelet-rich plasma in infertile patients with a thin uterine lining
The study evaluated the effectiveness of injections of autologous endometrial cells (AEC) and platelet-rich plasma (PRP) in infertile women with a thin endometrium (uterine lining). The study found that PRP injections and injections of AEC suspended in PRP improved the cells and thickness of the endometrium.


diabetes mellitus | Research | Lifestyle | 10 pages | source: Diabetes Care | Added May 17, 2023
How does physical activity affect the occurrence of major diabetes-related complications?
This study evaluated evidence on the association between physical activity and major diabetes-related complications in patients with diabetes. The authors concluded that physical activity was associated with a reduction in the occurrence of major diabetes-related complications, even if performed at levels lower than recommended.


prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added May 16, 2023
Evaluating the effectiveness and safety of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.
This study evaluated the effectiveness and safety of rezvilutamide (Ariane) versus bicalutamide (Casodex) in combination with androgen deprivation therapy (ADT) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that rezvilutamide in combination with ADT significantly improved the survival outcomes compared with bicalutamide plus ADT with manageable side effects in these patients.


coronary artery disease | Research | Lifestyle | 10 pages | source: Lancet (London, England) | Added May 16, 2023
Comparing the effects of a Mediterranean versus a low-fat diet in the secondary prevention of cardiovascular events in patients with coronary artery disease.
This study compared the effects of a Mediterranean versus a low-fat diet in the secondary prevention of major cardiovascular events (MACE) in patients with established coronary artery disease (CAD). The data showed that in secondary prevention, the Mediterranean diet was more effective in preventing MACEs compared to a low-fat diet in these patients.


colorectal cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added May 14, 2023
Comparing the effectiveness of TAS-102 versus regorafenib for the treatment of patients with metastatic colorectal cancer.
This study compared the effectiveness of TAS-102 (Lonsurf; trifluridine-tipiracil) versus regorafenib (Stivarga) for the treatment of patients with metastatic colorectal cancer (mCRC). The data showed that TAS-102 had better oncologic outcomes than regorafenib in these patients.


erectile dysfunction | Research | Treatment | 10 pages | source: Frontiers in Endocrinology | Added May 14, 2023
Evaluating the effectiveness of combining low-intensity extracorporeal shock wave therapy with vacuum erectile device for the treatment of patients with diabetes and erectile dysfunction.
This study evaluated the effectiveness of combining low-intensity extracorporeal shock wave therapy (Li-ESWT) with a vacuum erectile device (VED) for the treatment of patients with diabetes mellitus (DM) and erectile dysfunction (ED) who were unresponsive to phosphodiesterase-5 (PDE5) inhibitors. The data showed that Li-ESWT combined with VED was more effective than Li-ESWT or VED therapy alone for the treatment of these patients.


parkinson's disease | Research | Treatment | 10 pages | source: Clinical neuropharmacology | Added May 14, 2023
Comparing the effects of different antidepressant therapies on depression symptoms in patients with Parkinson’s disease.
This study compared the effectiveness of different antidepressant therapies on depression in patients with Parkinson’s disease (PD). The data showed that escitalopram (Cipralex), pramipexole (Mirapex), and repetitive transcranial magnetic stimulation (rTMS) were more effective than routine treatment in these patients. After 4 weeks, escitalopram showed better antidepressant effects and improved patients' quality of life and did not worsen motor function.


prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added May 14, 2023
Evaluating the effects of olaparib plus abiraterone regarding patient-reported outcomes in patients with metastatic castration-resistant prostate cancer patients
This study compared the effects on patient-reported outcomes (PROs) of using olaparib (Lynparza) plus abiraterone (Zytiga) versus placebo plus abiraterone for the treatment of metastatic castration-resistant prostate cancer (mCRPC). The study found that adding olaparib to abiraterone in these patients did not significantly impact patient-reported pain and health-related quality of life (HRQOL) compared to abiraterone alone (plus placebo).


benign prostatic hyperplasia | Research | Treatment | 10 pages | source: Urology | Added May 14, 2023
Evaluating the outcomes of single-pass versus multiple-pass during aquablation in patients with urinary symptoms due to benign prostatic hyperplasia.
This study evaluated the outcomes of single-pass versus multiple-pass during aquablation in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). The data showed that treatment with multiple passes during aquablation improved the urinary outcomes compared to a single pass in these patients.


hypertension | Research | Lifestyle | 10 pages | source: Journal of the American Heart Association | Added May 14, 2023
Evaluating the association between omega-3 polyunsaturated fatty acids dosage and blood pressure in patients with hypertension.
This study evaluated the association between omega-3 polyunsaturated fatty acids (PUFA) dosage (amount of drug administered) and blood pressure (BP) in patients with hypertension (high BP). The data showed that the optimal combined intake of omega-3 fatty acids for lowering BP is likely between 2 g/day and 3 g/day in these patients.